3. 结构
3.1 二维结构
3.2 三维结构
-1
-2
-3
24 24 0 1 0 0 0 0 0999 V2000
-1.0949 -1.5416 1.8953 O 0 0 0 0 0 0 0 0 0 0 0 0
3.2613 -0.1289 0.0667 O 0 5 0 0 0 0 0 0 0 0 0 0
1.7696 -1.6838 -0.3531 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.2775 0.2123 -0.1746 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.1860 2.3677 0.2375 N 0 0 0 0 0 0 0 0 0 0 0 0
2.0571 -0.4776 -0.1029 N 0 3 0 0 0 0 0 0 0 0 0 0
-0.8566 -1.1086 -0.4697 C 0 0 1 0 0 0 0 0 0 0 0 0
-1.7860 -1.5885 0.6522 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.9834 1.3550 -0.0208 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.5617 -1.1245 -1.8278 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0376 0.4762 -0.0126 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0753 1.8268 0.2435 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4550 1.4155 -0.1338 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.1275 -1.8922 -0.5492 H 0 0 0 0 0 0 0 0 0 0 0 0
-2.0844 -2.6285 0.4745 H 0 0 0 0 0 0 0 0 0 0 0 0
-2.7088 -1.0250 0.7751 H 0 0 0 0 0 0 0 0 0 0 0 0
-1.8573 -2.1505 -2.0785 H 0 0 0 0 0 0 0 0 0 0 0 0
-2.4630 -0.5199 -1.9092 H 0 0 0 0 0 0 0 0 0 0 0 0
-0.8758 -0.7868 -2.6138 H 0 0 0 0 0 0 0 0 0 0 0 0
1.9428 2.4429 0.4335 H 0 0 0 0 0 0 0 0 0 0 0 0
-3.0115 0.5218 -0.3773 H 0 0 0 0 0 0 0 0 0 0 0 0
-2.8631 1.7835 0.8150 H 0 0 0 0 0 0 0 0 0 0 0 0
-2.7166 2.1578 -0.8972 H 0 0 0 0 0 0 0 0 0 0 0 0
-0.3014 -2.0975 1.8116 H 0 0 0 0 0 0 0 0 0 0 0 0
1 8 1 0 0 0 0
1 24 1 0 0 0 0
2 6 1 0 0 0 0
3 6 2 0 0 0 0
4 7 1 0 0 0 0
4 9 1 0 0 0 0
4 11 1 0 0 0 0
5 9 2 0 0 0 0
5 12 1 0 0 0 0
6 11 1 0 0 0 0
7 8 1 0 0 0 0
7 10 1 0 0 0 0
7 14 1 0 0 0 0
8 15 1 0 0 0 0
8 16 1 0 0 0 0
9 13 1 0 0 0 0
10 17 1 0 0 0 0
10 18 1 0 0 0 0
10 19 1 0 0 0 0
11 12 2 0 0 0 0
12 20 1 0 0 0 0
13 21 1 0 0 0 0
13 22 1 0 0 0 0
13 23 1 0 0 0 0
M CHG 2 2 -1 6 1
4. 国际命名与标识
4.1 IUPAC Name
2-(2-methyl-5-nitroimidazol-1-yl)propan-1-ol
4.2 InChl
InChI=1S/C7H11N3O3/c1-5(4-11)9-6(2)8-3-7(9)10(12)13/h3,5,11H,4H2,1-2H3
4.3 InChlKey
QBBJCFDTZBBBRB-UHFFFAOYSA-N
4.4 Canonical SMILES
CC1=NC=C(N1C(C)CO)[N+](=O)[O-]
4.5 lsomeric SMILES
-
4.6 SDF文件
5. 波谱数据
5.1 13C核磁共振谱(13C NMR)
5.2 1H核磁共振谱(1H NMR)
5.3 质谱(MS)
5.4 红外光谱(IR)
5.5 紫外/可见光谱(UV/Vis)
6. 相关药材
7. 相关靶点
8. 相关疾病